What Research Peptide COAs Reveal About Purity Claims and Testing Gaps

Purity is usually the first figure people notice on a COA. For peptides, high-performance liquid chromatography, or HPLC, is commonly used to examine chromatographic purity and related impurities. 

However, “99% purity” without identifying the method provides limited context. The USP explains that peptide quality characterization can involve chromatography, mass spectrometry, NMR, and other techniques, depending on the attribute being measured.  

This is why research peptide COAs are more useful when they state the method and include supporting analytical data. 

Purity Does Not Automatically Confirm Identity 

A sample can produce a dominant chromatographic peak without that peak, by itself, proving the material has the expected molecular identity. 

U.S. Food and Drug Administration guidance makes this distinction clear. Identification testing should be specific enough to distinguish the intended substance from compounds with closely related structures. The agency also notes that identification based only on a single chromatographic retention time is generally not considered sufficiently specific.  

That means stronger research peptide COAs may pair chromatographic purity testing with another technique, such as mass spectrometry, to provide separate evidence related to identity. 

The COA Should Match the Actual Batch 

A certificate has much less value if researchers cannot determine which material it represents. Check the product name, lot or batch number, testing date, and sample or report identifier. 

This becomes especially useful when browsing a peptide shop where several strengths or products may be listed together. Labels such as KLOW 80mg, GHK-Cu 100mg, or Selank 10mg should not be matched to a certificate simply because the peptide name looks similar. The document should clearly correspond to the specific batch being evaluated. 

Batch traceability helps distinguish actual product documentation from a generic example COA. 

High Purity Can Still Leave Testing Gaps 

Chromatographic purity should not be interpreted as a complete inventory of everything that could be present in a sample. 

USP identifies impurities and degradation products as important quality considerations and notes that different analytical approaches may be needed to characterize peptide materials properly.  

For example, a purity figure may not automatically tell you about residual solvents, moisture, inorganic residues, counterions, microbial contamination, or every possible degradation product. Whether those characteristics were evaluated depends on the scope of testing. 

This is one reason research peptide COAs should be read according to what they actually measure, not what readers assume they prove. 

Analytical Procedure Quality Also Matters 

Even a familiar analytical method needs to be appropriate for its intended purpose. Simply writing “HPLC tested” or “MS confirmed” does not explain how well the procedure performs. 

FDA's Q2(R2) guidance provides a framework for validating analytical procedures so they can produce results suitable for their intended analytical purpose.  

When reviewing a COA, look for clearly named tests, understandable results, test dates, laboratory information, and supporting chromatograms or spectra where provided. Those details give the reported numbers useful context. 

Conclusion 

The most useful research peptide COAs do more than display an impressive purity percentage. They help connect a specific batch to clearly identified analytical testing and show what was actually measured. 

Researchers should separate purity from identity, check batch information, identify the analytical methods used, and note which quality characteristics were not examined. A COA should be treated as evidence for the tests it reports, not as automatic proof of every aspect of quality, safety, or suitability. 

FAQs 

Can a COA be valid without showing a chromatogram? 

Possibly. However, access to supporting analytical data can provide additional context for understanding how the reported result was generated. 

What is a reference standard in peptide testing? 

It is a characterized material used as a comparison during analytical testing. USP emphasizes that appropriate reference standards support reliable identity and quantitative measurements. Does a newer COA automatically mean better testing? 

No. The testing date provides traceability, but the methods, sample identification, and analytical evidence determine how informative the document is. 

Can the same COA cover several production lots? 

Researchers should look for batch-specific documentation. Different lots may have different analytical results and should not automatically be represented by one report. 

Does a COA prove a research peptide is suitable for human use? 

No. A COA reports specified analytical findings. It does not by itself establish regulatory approval, clinical safety, or suitability for human use.